Clinical Trial Update: Screening of TMA Patients für ADAMTS13 Activity (Adamscreen)

View source ↗

Summary

This document notes that the Adamscreen study (NCT02373267) is screening patients with thrombotic microangiopathy for ADAMTS13 activity, with the status listed …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Thrombotic Microangiopathy

Snippet

Sponsor: University of Cologne | Conditions: Thrombotic Microangiopathies | Status: UNKNOWN